亨斯曼材料 HUN 深 滬
等待開盤 03-26 09:30:00 美东时间
12.37
+0.960
+8.41%
華盛通- 最 高12.38
- 今 開11.73
- 成交量 523.26万股
- 最 低 11.65
- 昨 收 11.41
- 總市值 21.52亿
- 52周最高 14.2925
- 市盈率 靜 --
- 換手率 3.01%
- 52周最低 7.12
- 委 比 57.13%
- 總股本 1.74亿
- 歷史最高 37.925
- 量 比 0.63
- 振 幅 6.40%
- 歷史最低 -0.32
- 每 手 1
- 風險率 1.67%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Shares of chemicals-related companies are trading higher amid continued military strikes across the Middle East and lack of progress on purported U.S.-Iran talks.
Shares of chemicals-related companies are trading higher amid continued militar...
03-25 02:06
Brent Hits $110, Rate-Hike Fears Hammer Stocks And Gold: What's Moving Markets Friday?
U.S. stocks fall to four-month lows as oil surges above $110, Treasury yields spike, and markets price a 50% chance of a Fed rate hike by October.
03-21 01:36
期权扫描 | 获Bernstein上调目标价，台积电期权成交激增256%！英伟达获一Call单押注涨至190美元
获Bernstein上调目标价，台积电期权成交激增256%！黄仁勋豪言万亿美元营收，英伟达获一Call单押注涨至190美元>>
03-17 19:45
Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy
A recent study published in the *Journal of Clinical Medicine* supports Vivos Therapeutics' belief that specific dental and facial morphologies are directly linked to the severity of obstructive sleep apnea (OSA). The study found that narrower palatal dental arches and higher palatal height are associated with more severe OSA. Vivos CARE devices, FDA-cleared for treating mild to severe OSA in adults and moderate-to-severe OSA in children, work by...
03-17 12:45
ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives
Telix Pharmaceuticals announced positive results from Part 1 of the ProstACT Global Phase 3 study for TLX591-Tx, a lutetium-177 radioantibody-drug conjugate. The study met its primary objectives, demonstrating acceptable safety, tolerability, and no new safety signals. Key findings include low-grade non-hematologic events, consistent dosimetry across cohorts, and no adverse drug-drug interactions. Hematologic events were transient and manageable....
03-09 23:19
Henry Schein, Vir Biotechnology, Ultra Clean Holdings And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were higher, with the Dow Jones index gaining around 200 points on ...
02-24 23:07
美股大行评级 | 潜在涨幅108.69%！Stephens & Co.维持圣玛丽石油勘测"超配"评级，上调目标价至49美元
今日重点评级关注：Stephens & Co.：维持圣玛丽石油勘测"超配"评级，目标价从48美元升至49美元；花旗：维持IDEAYA Biosciences"买入"评级，目标价从64美元升至65美元
02-20 15:57
Huntsman downgraded on valuation at J.P. Morgan after strong YTD run-up
Huntsman (HUN) -4.2% in Thursday's trading as J.P. Morgan downgraded the chemicals manufacturer to Neutral from Overweight with a $14 price target, saying the current share price now reasonably discou...
02-20 03:35
JP Morgan Downgrades Huntsman to Neutral, Raises Price Target to $14
JP Morgan analyst Jeffrey Zekauskas downgrades Huntsman (NYSE:HUN) from Overweight to Neutral and raises the price target from $11 to $14.
02-19 21:45
U.S. RESEARCH ROUNDUP-eBay, Huntsman, Palo Alto
U.S. RESEARCH ROUNDUP-eBay, Huntsman, Palo Alto Feb 19 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including eBay, Huntsman and Palo Alto , on Thursday. HIGHLIGHTS * eBay EBAY.O : Piper Sandler raises target price to $105 from
02-19 16:20
